Market Overview

The North America aortic stent graft market plays a crucial role in addressing one of the most critical conditions affecting the aorta, the body’s largest artery. Aortic aneurysms, particularly abdominal and thoracic aneurysms, pose serious risks and require advanced treatment options such as stent grafts. These devices are used to treat aortic aneurysms by reinforcing the weakened area of the aorta, preventing rupture and enhancing the patient's survival rate. With increasing life expectancy and an aging population in North America, the demand for aortic stent grafts has surged. Moreover, advancements in stent graft materials and designs have significantly contributed to market growth. The market's importance lies in its ability to offer minimally invasive solutions to a condition that once required open surgery, offering improved patient outcomes and shorter recovery times.

Market Size and Share

The North American aortic stent graft market was valued at USD 3.1 billion in 2024 and is expected to experience a robust growth rate, projected to expand at a compound annual growth rate (CAGR) of 5.8% during the forecast period of 2025-2034. By 2034, the market is anticipated to reach USD 5.2 billion. This growth is primarily driven by the increasing prevalence of aortic aneurysms, advancements in medical technologies, and a rising geriatric population, all of which contribute to the growing demand for more efficient, less invasive treatment options. The region's healthcare system is also highly developed, which allows for the quick adoption of innovative medical solutions like aortic stent grafts.

Market Trends

• Growing Geriatric Population
  The increasing number of elderly individuals in North America is one of the primary factors driving the demand for aortic stent grafts. Aging is a significant risk factor for aortic aneurysms, particularly abdominal and thoracic aneurysms, which commonly occur in individuals over the age of 60. With a growing geriatric population, the demand for treatments like aortic stent grafts is expected to increase, contributing significantly to the market's growth.
• Advancements in Stent Graft Materials and Design
  Continuous advancements in stent graft materials and design have enhanced the performance, durability, and ease of implantation of these devices. Innovations such as hybrid stent grafts, bioresorbable materials, and more flexible designs are making procedures safer and more effective. As these technologies improve, stent grafts become a more attractive solution for physicians and patients, thereby propelling market growth.
• Increasing Awareness and Early Diagnosis
  Improved awareness of aortic aneurysms, combined with advances in diagnostic imaging, has led to earlier detection of this potentially life-threatening condition. Early detection of aneurysms allows for timely interventions using stent grafts, preventing complications such as rupture. As diagnostic tools become more widely available and effective, the adoption of aortic stent grafts is likely to increase, fueling further market expansion.
• Minimally Invasive Nature of Stent Graft Procedures
  The minimally invasive nature of stent graft surgeries is a major driver of their adoption. Compared to traditional open surgery, stent graft procedures offer shorter recovery times, reduced risks of complications, and better overall outcomes. This has made the treatment of aortic aneurysms much more patient-friendly, which is attracting a wider patient base and increasing the popularity of these devices in the North American healthcare system.

Market Analysis

• Product Segmentation: Abdominal and Thoracic Aortic Stent Grafts
  The aortic stent graft market is mainly divided into two types: abdominal aortic stent grafts and thoracic aortic stent grafts. Abdominal aortic stent grafts account for a significant share of the market due to the higher prevalence of abdominal aortic aneurysms (AAA). However, thoracic aortic stent grafts are also seeing growing demand as thoracic aneurysms become increasingly recognized and diagnosed. The growth in both segments reflects a broader trend toward more targeted and specialized treatments.
• End User Segmentation: Hospitals and Ambulatory Surgical Centers
  Hospitals remain the primary end-users of aortic stent grafts due to the availability of specialized infrastructure, medical teams, and diagnostic equipment necessary for the implantation of these devices. Ambulatory surgical centers (ASCs) are also increasingly adopting stent graft procedures, driven by the rising trend of outpatient procedures. ASCs offer cost-effective and convenient alternatives to hospital settings, attracting a significant patient base.
• Region-Based Growth: United States vs. Canada
  The United States holds the largest share of the North American aortic stent graft market, owing to its advanced healthcare infrastructure, high healthcare expenditure, and large patient population. Canada is also seeing growth in this market, although at a slightly slower pace, due to a smaller population base and lower incidence rates of aortic aneurysms. Nonetheless, both countries are expected to contribute significantly to the overall market expansion.
• Technological Advancements Driving Market Dynamics
  Technological advancements in the field of aortic stent grafts are a critical driver of market growth. Innovations such as drug-eluting stents, hybrid grafts, and self-expanding stents are improving patient outcomes and reducing the need for repeat procedures. These advancements are attracting more hospitals, surgical centers, and patients to adopt stent graft procedures, which is expected to drive the market over the forecast period.

Scope of the Report

This report provides a detailed analysis of the North American aortic stent graft market, offering insights into historical trends, current market dynamics, and future projections. It includes a comprehensive analysis of the market by product type (abdominal and thoracic aortic stent grafts), end user (hospitals, ambulatory surgical centers, others), and regional segments (United States and Canada). Additionally, the report examines key industry drivers, constraints, and opportunities in the market, providing stakeholders with valuable insights to inform strategic decisions.

Market Growth

The North American aortic stent graft market is expected to grow significantly due to several factors. First, the aging population is more susceptible to aortic aneurysms, leading to increased demand for stent grafts. Second, advancements in stent graft technologies, such as flexible materials, customized grafts, and improved delivery systems, are making these devices more effective and easier to implant. Third, increasing awareness and early diagnosis of aortic aneurysms are contributing to the rise in treatment adoption. These factors collectively make the market ripe for growth, with an estimated market size of USD 5.2 billion by 2034.

Get a Free Sample Report with a Table of Contents

Recent Developments Challenges

• Technological Innovations in Stent Graft Materials
  Recent developments in stent graft materials, such as bioresorbable stents and hybrid materials, have improved the flexibility, durability, and performance of these devices. These innovations are making stent graft procedures safer and more efficient, contributing to the overall growth of the market.
• Regulatory Challenges and Approvals
  The approval process for new stent graft technologies can be lengthy and complex due to the rigorous regulatory standards set by bodies like the FDA. Delays in obtaining approvals may slow down the rate of market expansion. However, advancements in regulatory frameworks are expected to streamline this process over time.
• Cost Considerations
  The cost of aortic stent grafts can be a barrier to their widespread adoption, especially in developing healthcare systems. As the cost of stent graft devices continues to decrease due to technological advancements and economies of scale, their adoption in both hospitals and ambulatory surgical centers is expected to rise.
• Competition from Alternative Treatments
  While aortic stent grafts are the gold standard for treating aortic aneurysms, competition from other medical technologies, including surgical interventions and emerging drug therapies, poses a challenge to market growth. However, the minimally invasive nature and better patient outcomes of stent graft procedures continue to position them favorably in the treatment landscape.

Key Players

Cook Medical, Inc.
Cook Medical is a leader in the aortic stent graft market, offering a wide range of high-quality devices for treating both abdominal and thoracic aortic aneurysms. Their advanced stent graft technologies focus on improving patient outcomes with better durability and flexibility, ensuring rapid adoption in hospitals and surgical centers.

W.L. Gore Associates
W.L. Gore Associates is known for its innovative aortic stent grafts, such as the Gore Excluder® device. The company's advanced graft materials, which include ePTFE (expanded polytetrafluoroethylene), ensure high performance and are widely used for endovascular aortic repairs. Their commitment to research and development continues to drive growth in the market.

Medtronic Plc.
Medtronic is a prominent player in the North American aortic stent graft market, offering a range of devices including the Endurant® Stent Graft. The company’s products are designed for both abdominal and thoracic aortic aneurysms and are known for their reliability and advanced technology, contributing to their widespread adoption.

MicroPort Scientific Corporation, Inc.
MicroPort Scientific Corporation is known for its innovations in the field of medical devices, including aortic stent grafts. Their stent graft solutions are known for their precision and performance, making them a preferred choice among healthcare providers. MicroPort continues to innovate in the stent graft market, offering high-quality solutions to meet patient needs.

Other companies involved in the North American aortic stent graft market include Lombard Medical, Inc., Endologix, Inc., Terumo Corporation, Cardinal Health Inc., Becton, Dickinson and Company, Cryolife Inc., and more, each contributing to the competitive landscape of the market.

FAQs

What is an aortic stent graft?
An aortic stent graft is a medical device used to treat aortic aneurysms by providing support to the aorta, reducing the risk of rupture. It is a minimally invasive alternative to open surgery.

How does aortic stent graft surgery work?
During the procedure, a stent graft is inserted through a catheter into the aorta. The device reinforces the weakened area of the aorta, preventing rupture and providing long-term support.

What are the types of aortic stent grafts?
There are two main types of aortic stent grafts: abdominal aortic stent grafts for abdominal aneurysms and thoracic aortic stent grafts for aneurysms in the chest area.

What are the benefits of aortic stent grafts?
Aortic stent grafts offer a minimally invasive treatment option, reducing recovery times and risks associated with traditional open surgery, leading to improved patient outcomes.

Which companies are leading the aortic stent graft market?
Key players in the aortic stent graft market include Cook Medical, Medtronic, W.L. Gore Associates, and MicroPort Scientific Corporation, among others. These companies are leading innovation and driving market growth.

Read Our Blogs

Top 7 Companies in the Global Portable Medical and Healthcare Devices Market in 2025

Top 7 Pediatric Medical Device Companies Manufacturers Worldwide | 2025